Allianz SE bought a new stake in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 18,968 shares of the semiconductor company's stock, valued at approximately $1,369,000.
Several other institutional investors and hedge funds have also recently modified their holdings of LRCX. West Oak Capital LLC increased its stake in shares of Lam Research by 50.9% during the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company's stock worth $29,000 after purchasing an additional 135 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of Lam Research by 5.7% in the third quarter. IHT Wealth Management LLC now owns 2,729 shares of the semiconductor company's stock worth $2,216,000 after acquiring an additional 147 shares during the last quarter. Community Bank N.A. increased its position in shares of Lam Research by 12.5% during the third quarter. Community Bank N.A. now owns 1,765 shares of the semiconductor company's stock worth $1,440,000 after purchasing an additional 196 shares in the last quarter. Algert Global LLC lifted its holdings in Lam Research by 40.5% in the 3rd quarter. Algert Global LLC now owns 694 shares of the semiconductor company's stock valued at $566,000 after purchasing an additional 200 shares in the last quarter. Finally, Stevens Capital Management LP lifted its holdings in Lam Research by 112.4% in the 3rd quarter. Stevens Capital Management LP now owns 427 shares of the semiconductor company's stock valued at $348,000 after purchasing an additional 226 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company's stock.
Lam Research Price Performance
LRCX stock traded up $0.95 during trading on Wednesday, reaching $73.78. 7,526,489 shares of the company were exchanged, compared to its average volume of 11,701,164. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. The stock's 50 day moving average price is $79.18 and its 200 day moving average price is $77.30. Lam Research Co. has a 52-week low of $68.87 and a 52-week high of $113.00. The company has a market cap of $94.71 billion, a P/E ratio of 22.41, a PEG ratio of 1.47 and a beta of 1.53.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. As a group, analysts predict that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Wednesday, March 5th will be issued a $0.23 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.92 dividend on an annualized basis and a yield of 1.25%. Lam Research's dividend payout ratio (DPR) is 27.96%.
Insider Activity
In other Lam Research news, SVP Seshasayee Varadarajan sold 110,080 shares of the business's stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $90.00, for a total value of $9,907,200.00. Following the completion of the transaction, the senior vice president now directly owns 179,084 shares in the company, valued at approximately $16,117,560. The trade was a 38.07 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.29% of the company's stock.
Wall Street Analysts Forecast Growth
LRCX has been the subject of a number of analyst reports. Wells Fargo & Company upped their price target on Lam Research from $82.00 to $85.00 and gave the company an "equal weight" rating in a research report on Thursday, January 30th. The Goldman Sachs Group cut their target price on Lam Research from $96.00 to $85.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Mizuho boosted their price target on shares of Lam Research from $87.00 to $100.00 and gave the company an "outperform" rating in a research report on Thursday, February 20th. Susquehanna upgraded shares of Lam Research from a "neutral" rating to a "positive" rating and raised their price objective for the stock from $75.00 to $125.00 in a research report on Thursday, February 20th. Finally, Sanford C. Bernstein upgraded shares of Lam Research from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $85.00 to $91.00 in a report on Thursday, January 30th. Six analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. Based on data from MarketBeat, Lam Research has a consensus rating of "Moderate Buy" and a consensus price target of $97.59.
Read Our Latest Stock Report on Lam Research
Lam Research Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.